Company: AGTX
Filing Date: 2025-07-16
Form Type: 10-K
Source: 0001477932-25-005077
Chunk: 199

Company: Agentix Corp.
Filing Date: 2025-07-16
Form: 10-K
Item: Item 3
Chunk 199
---
 reported amounts of assets, liabilities, revenues and expenses, and related disclosure of contingent assets and liabilities. On an ongoing basis, we evaluate our estimates based on historical experience and on various other assumptions that are believed to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities that are not readily apparent from other sources. Actual results may differ from these estimates under different assumptions or conditions. For the periods presented, we concluded that no accounting policies required such extensive judgment or complexity that they should be classified as critical to understanding our financial condition or operating results.

Recent Accounting Pronouncements

We do not expect the adoption of recently issued accounting pronouncements to have a significant impact on its results of operations, financial position or cash flow.

RESULTS OF OPERATIONS

Year Ended March 31, 2025 as compared to Year Ended March 31, 2024:

We recorded no revenues during the year ended March 31, 2025 and 2024.

For the year ended March 31, 2025, professional fees were $262,366 as compared to $222,999 for the year ended March 31, 2024, an increase of $39,367. The Increase in professional fees mainly to an increase in accounting and consulting fees.

 13Table of Contents

For the year ended March 31, 2025, we incurred total research and development expenses of $180,987 as compared to $175,268 for our year ended March 31, 2024, an increase of $5,719. The increase was mainly related to increase in R&D consulting costs.

For the year ended March 31, 2025, general and administrative expenses were $69,898 as compared to $346,543 for our year ended March 31, 2024, a decrease of $276,645. The decrease was mainly related to a decrease in royalty fee we incurred related to patents in the prior period, compared to the prior period.

For the year ended March 31, 2025 and 2024, foreign exchange loss was $11,128 and $17,929, respectively.

For the year ended March 31, 2025 and 2024, interest expense, net was $42,669 and $21,034, respectively. The net increase in interest expense related to our increase in loan activity during the year ended March 31, 2025 as compared to our year ended March 31, 2024.